Pasar al contenido principal

TERAPIA EPIGENETICA PARA PROMOVER LA RECUPERACION FUNCIONAL DESPUES DE UNA LESION DE MEDULA ESPINAL

PID2019-108496RA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE BARCELONA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Transient cerebral ischaemia alters mesenteric arteries in hypertensive rats, Limited reversal despite suberoylanilide hydroxamic acid cerebroprotection

  • Díaz Pérez, Andrea|||0009-0008-2215-6344
  • Lope-Piedrafita, Silvia|||0000-0002-8127-6425
  • Pérez, Belén|||0000-0001-5801-1704
  • Vázquez-Sufuentes, Paula|||0009-0001-3369-9087
  • Rodriguez-Garcia, Maria
  • Briones, Ana|||0000-0001-8218-5579
  • Navarro, X. (Xavier)|||0000-0001-9849-902X
  • Penas Pérez, Clara|||0000-0003-0554-3832
  • Jiménez Altayó, Francesc|||0000-0002-9034-2041
Stroke induces brain injury, especially severe in hypertensive patients, and elevates mortality rates through non-neurological complications. However, the potential effects of a transient ischaemic episode on the peripheral vasculature of hypertensive individuals remain unclear. We investigated whether transient cerebral ischaemia (90 min)/reperfusion (1 or 8 days) induces alterations in mesenteric resistance artery (MRA) properties in adult male spontaneously hypertensive rats (SHR). In addition, we assessed whether the reported cerebroprotective effects of suberoylanilide hydroxamic acid (SAHA; 50 mg/kg; administered intraperitoneally at 1, 4, or 6 h after reperfusion onset) extend over several days and include beneficial effects on MRAs. Functional and structural properties of MRAs were examined at 1- and 8-days post-stroke. Nuclei distribution, collagen content, and oxidative stress were assessed. Ischaemic brain damage was evaluated longitudinally using magnetic resonance imaging. Following stroke, MRAs from SHR exhibited non-reversible impaired contractile responses to the thromboxane A receptor agonist U46619. Stroke increased the MRA cross-sectional area, wall thickness, and wall/lm ratio due to augmented collagen deposition. These changes were partially sustained 8 days later. SAHA did not improve U46619-induced contractions but mitigated stroke-induced oxidative stress and collagen deposition, preventing MRA remodelling at 24 h of reperfusion. Furthermore, SAHA induced sustained cerebroprotective effects over 8 days, including reduced brain infarct and oedema, and improved neurological scores. However, SAHA had minimal impact on chronic MRA contractile impairments and remodelling. These findings suggest that stroke causes MRA changes in hypertensive subjects. While SAHA treatment offers sustained protection against brain damage, it cannot fully restore MRA alterations.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Transient cerebral ischaemia alters mesenteric arteries in hypertensive rats: Limited reversal despite suberoylanilide hydroxamic acid cerebroprotection

  • Díaz-Pérez, Andrea
  • Lope-Piedrafita, Silvia
  • Pérez, Belén
  • Vázquez-Sufuentes, Paula
  • Rodríguez García, María
  • Briones, Ana M
  • Navarro, Xavier
  • Penas, Clara
  • Jiménez-Altayó, Francesc
Stroke induces brain injury, especially severe in hypertensive patients, and elevates mortality rates through non-neurological complications. However, the potential effects of a transient ischaemic episode on the peripheral vasculature of hypertensive individuals remain unclear. We investigated whether transient cerebral ischaemia (90 min)/reperfusion (1 or 8 days) induces alterations in mesenteric resistance artery (MRA) properties in adult male spontaneously hypertensive rats (SHR). In addition, we assessed whether the reported cerebroprotective effects of suberoylanilide hydroxamic acid (SAHA; 50 mg/kg; administered intraperitoneally at 1, 4, or 6 h after reperfusion onset) extend over several days and include beneficial effects on MRAs. Functional and structural properties of MRAs were examined at 1- and 8-days post-stroke. Nuclei distribution, collagen content, and oxidative stress were assessed. Ischaemic brain damage was evaluated longitudinally using magnetic resonance imaging. Following stroke, MRAs from SHR exhibited non-reversible impaired contractile responses to the thromboxane A2 receptor agonist U46619. Stroke increased the MRA cross-sectional area, wall thickness, and wall/lm ratio due to augmented collagen deposition. These changes were partially sustained 8 days later. SAHA did not improve U46619-induced contractions but mitigated stroke-induced oxidative stress and collagen deposition, preventing MRA remodelling at 24 h of reperfusion. Furthermore, SAHA induced sustained cerebroprotective effects over 8 days, including reduced brain infarct and oedema, and improved neurological scores. However, SAHA had minimal impact on chronic MRA contractile impairments and remodelling. These findings suggest that stroke causes MRA changes in hypertensive subjects. While SAHA treatment offers sustained protection against brain damage, it cannot fully restore MRA alterations., This work was supported by grants: i) PID2020–113634RB-C22/AEI/10.13039/501100011033 and PID2019–108496RA-I00/AEI/10.13039/501100011033 from Ministerio de Ciencia e Innovación and Agencia Estatal de Investigación of Spain; ii) 2021 SGR 00969 from Generalitat de Catalunya; iii) Project NEUROGRAPH, GraphCAT: Comunitat Emergent de Grafè a Catalunya (grant 001-P-001702), by FLAG-ERA JTC 2021 project RESCUEGRAPH, by the Agencia Estatal de Investigación of Spain projects PCI2021–122075; iv) RICORS TERAV (grant RD21/0017/008); and v) CIBERNED (grant CB06/05/1105) from the Instituto de Salud Carlos III of Spain, co-funded by European Union (NextGenerationEU, Recovery, Transformation and Resilience Plan)., Peer reviewed
Dipòsit Digital de Documents de la UAB
Datos de investigación Set de datos (Dataset)

Raw data from Palomés-Borrajo et al, Journal of Neuroscience Research, 2021

  • Palomés Borrajo, Georgina|||0000-0002-8217-2054
  • Navarro, X. (Xavier)|||0000-0001-9849-902X
  • Penas Pérez, Clara|||0000-0003-0554-3832
This dataset contains the recordings used for the statistical analysis collected in the article "BET protein inhibition in macrophages enhances dorsal root ganglion outgrowth in female mice", submitted to the Journal of Neuroscience Research. It contains numerical data of qPCRs and electrophysiological recordings derived from the in vivo experiments, as well as information of neurite outgrowth of DRG explants, drug toxicity and Western Blots of the ex vivo research. Data is classified in several tabs according to the figures found in the paper.